Sort
39,280 grants matching “leukemia”
Discovery and Engineering of Plant Natural Product Pathways
$305,879Elizabeth Susan Sattely · Stanford University · R01 · FY2023 · GM
Mechanism of Action of Retinoic Acid Using CD38
$305,862Andrew Yen · Cornell University · R01 · FY2013 · CA
MLL-FUSIONS AND COOPERATING MUTATIONS IN ACUTE LEUKEMIA
$305,849Michael J Thirman · Loyola University Chicago · P01 · FY2007 · CA
Mechanisms of Leukemogenesis in Down Syndrome
$305,841John D Crispino · Northwestern University At Chicago · R01 · FY2008 · CA
The role of SEPT9 in cell proliferation and oncogenesis
$305,838Elizabeth M Petty · University Of Michigan At Ann Arbor · R01 · FY2006 · CA
8-Chloro-Adenosine for Treatment of CLL (IND 68,229)
$305,800William George Wierda · University Of Tx Md Anderson Can Ctr · R21 · FY2009 · CA
8-Chloro-Adenosine for Treatment of CLL (IND 68,229)
$305,800William George Wierda · University Of Tx Md Anderson Can Ctr · R21 · FY2010 · CA
Regulation of Mast Cell Function by Inhibitory Molecules
$305,795Anna Huttenlocher · University Of Wisconsin-Madison · R01 · FY2010 · AI
CHRONIC MYELOGENOUS LEUKEMIA AND BCR-ABL SUBSTRATES
$305,775Oregon Health And Science University · R01 · FY2001 · CA
CHRONIC MYELOGENOUS LEUKEMIA AND BCR-ABL SUBSTRATES
$305,775Oregon Health And Science University · R01 · FY2004 · CA
CHRONIC MYELOGENOUS LEUKEMIA AND BCR-ABL SUBSTRATES
$305,775Oregon Health And Science University · R01 · FY2000 · CA
CHRONIC MYELOGENOUS LEUKEMIA AND BCR-ABL SUBSTRATES
$305,775Oregon Health And Science University · R01 · FY2003 · CA
CHRONIC MYELOGENOUS LEUKEMIA AND BCR-ABL SUBSTRATES
$305,775Oregon Health And Science University · R01 · FY2002 · CA
Core C: Animal Models
$305,738Stefan Niewiesk · Ohio State University · P01 · FY2016 · CA
Mechanisms of Pbx-directed Genetic & Transcriptional Control of Limb Development
$305,718Licia Selleri · University Of California, San Francisco · R01 · FY2016 · HD
Mechanisms of Leukemogenesis in Down Syndrome
$305,707John D Crispino · Northwestern University At Chicago · R01 · FY2007 · CA
Re-engineering the CRC Integrated Information Management System
$305,700Philip R.o. Payne · Ohio State University · R01 · FY2011 · CA
Probing mitochondria and personalizing leukemia therapy with BH3 profiling
$305,698Anthony G Letai · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Discovery and Engineering of Plant Natural Product Pathways
$305,696Elizabeth Susan Sattely · Stanford University · R01 · FY2022 · GM
NK Cells and Their Receptor in Leukemia Therapy
$305,687Jeffrey S Miller · University Of Minnesota · P01 · FY2012 · CA
Phase II trial of valproic acid in myelodysplasia
$305,682Peter S Klein · University Of Pennsylvania · R21 · FY2006 · CA
Advanced development of human mutant IDH1 inhibitors (Chemical Biology Consortium/NCI Experimental Therapeutics Collaboration)
$305,662Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
NPC/MIPE Toxicity Screen of IDH1 Inhibitors against Cholangiocarcinoma Cell Lines
$305,662Min Shen · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Targeting Ceramide Metabolism in AML
$305,658Mark Kester · Pennsylvania State Univ Hershey Med Ctr · P01 · FY2013 · CA
Regulation of TAL1/SCL in T-Cell Leukemia
$305,650Suming Huang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2019 · CA